Tolperisone Hydrochloride Sustained Release Tablets 450 mg

About Tolperisone Hydrochloride Sustained Release Tablets 450 mg

Tolperisone Hydrochloride Sustained Release Tablets 450 mg, marketed under the brand name TOPERITIME 450, contain tolperisone hydrochloride, a centrally acting muscle relaxant. Tolperisone is used to reduce abnormal muscle stiffness, increased muscle tone, and spasms associated with certain neurological and musculoskeletal conditions. It is believed to act primarily on nerve pathways in the brain and spinal cord that influence muscle contraction, although its precise mechanism is not completely established.

The sustained-release formulation is designed to provide prolonged drug release. The exact composition, release characteristics, and approved indications of TOPERITIME 450 should always be confirmed against the manufacturer's product label.

Uses

TOPERITIME 450 may be prescribed for conditions involving muscle spasticity or increased muscle tone when tolperisone treatment is considered appropriate. Tolperisone has been used in different countries for muscle spasms and spasticity; however, approved uses vary by country. The European Medicines Agency (EMA) restricted oral tolperisone's use in the EU to symptomatic treatment of post-stroke spasticity in adults, following a review of efficacy and hypersensitivity risks.

Therefore, TOPERITIME 450 should be used only for an indication approved by the relevant regulatory authority and prescribed by a qualified healthcare professional.

Benefits

The primary potential benefit of Tolperisone Hydrochloride Sustained Release Tablets 450 mg is the reduction of excessive muscle tone and stiffness. By influencing nerve impulses involved in muscle contraction, tolperisone may help reduce spasticity and associated movement difficulties in appropriately selected patients.

A sustained-release dosage form may be convenient when prolonged drug release is appropriate. However, the clinical benefits and suitability of the formulation depend on the patient's diagnosis, treatment plan, and response to therapy. It should not be considered a general-purpose treatment for ordinary muscle pain without professional medical advice.

Dosage

The dosage of TOPERITIME 450 should be determined by the prescribing physician based on the patient's condition, age, response to treatment, other medicines, and relevant medical history. The 450 mg strength should not be interpreted as a universal recommended daily dose.

Tolperisone-containing medicines are generally recommended to be taken after meals with a glass of water, as insufficient food intake may reduce the medicine's bioavailability. Because TOPERITIME 450 is described as a sustained-release tablet, it should be swallowed according to the manufacturer's instructions rather than crushed or altered unless a healthcare professional specifically advises otherwise.

Side Effects

Possible adverse effects of tolperisone include headache, dizziness, nausea, abdominal discomfort, muscle weakness, and other gastrointestinal or neurological symptoms. Individual responses can vary.

An important safety concern with tolperisone is hypersensitivity or allergic reactions. Reported reactions range from skin reactions to severe systemic reactions, including anaphylactic shock. Symptoms may include rash, itching, flushing, swelling, wheezing, difficulty breathing or swallowing, rapid heartbeat, and low blood pressure.

Precautions and Warning

Patients should inform their healthcare professional about any previous allergy to tolperisone, eperisone, or other medicines, as well as any history of drug allergies or allergic conditions. People with liver or kidney problems may require additional medical assessment and monitoring. Tolperisone use is not recommended in severe hepatic impairment according to EMA product information.

If symptoms suggesting a serious allergic reaction develop, treatment should be stopped and urgent medical attention should be obtained. Patients should also inform their doctor about all prescription medicines, over-the-counter products, and supplements they use before starting treatment.

Conclusion

Tolperisone Hydrochloride Sustained Release Tablets 450 mg (TOPERITIME 450) are formulated to provide the muscle-relaxant action of tolperisone in a sustained-release dosage form. The medicine may help manage muscle stiffness and spasticity when appropriately prescribed. Because tolperisone has important hypersensitivity warnings and its approved indications differ between countries, professional guidance is essential. Always follow the prescribed dose and the specific instructions provided with the TOPERITIME 450 product.